Carvedilol Tablet, Film Coated
Product Images NDC 67296-1901

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 67296-1901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-00)

Label for Carvedilol Tablets, USP 12.5 mg, film-coated oral tablets. The package contains 1000 tablets, distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. It includes storage and handling instructions, the NDC 72888-036-00, and a note that it is Rx only.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-01)

Label for Carvedilol Tablets, USP 12.5 mg, featuring 100 film-coated tablets. Distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited. Includes storage instructions, dosage reference, barcode, and NDC 72888-036-01. The design highlights the strength in pink with relevant regulatory and packaging information.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-30)

Carvedilol Tablets USP 12.5 mg film coated tablet label showing 30 tablets per bottle. The label includes storage instructions, manufacturer and distributor information, and a barcode. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-05)

Carvedilol Tablets, USP 12.5 mg film-coated tablet label showing packaging for 500 tablets. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. The label includes storage instructions, dosage caution, and a barcode.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-00)

Carvedilol Tablets USP 25 mg film-coated tablets label showing a package of 1000 tablets. Distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited in India. Includes storage instructions and barcode on white background with blue dosage highlight and Advagen logo.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-01)

Carvedilol Tablets, USP 25 mg film-coated tablets label showing 100 tablets per container. Distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited in India. The label includes storage instructions, dosage note, barcodes, and a designated overprinting area.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-30)

Carvedilol Tablets, USP 25 mg film-coated tablets packaging label showing 30 tablets per container. The label includes storage instructions, sealing warnings, and identifies Advagen Pharma Limited as distributor and Rubicon Research Private Limited as manufacturer. NDC 72888-037-30 is visible with Rx Only status.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-05)

Label for Carvedilol Tablets, USP 25 mg, film-coated, 500 count. The label shows storage instructions to keep below 30°C and protect from moisture. It lists the distributor as Advagen Pharma Limited, Plainsboro, NJ, and the manufacturer as Rubicon Research Private Limited, India. The label includes a barcode and cautions about the tablet safety seal.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-00)

Label for Carvedilol Tablets, USP 3.125 mg, with a package quantity of 1000 tablets. The label includes storage instructions and distribution information, listing Advagen Pharma Limited as the distributor and Rubicon Research Private Limited as the manufacturer in India. The label features barcodes and cautions about the seal integrity and dosage information.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-01)

Carvedilol Tablets, USP 3.125 mg film-coated tablets label showing packaging information including drug strength, quantity (100 tablets), dispensing instructions, storage conditions, bar code, manufacturer (Rubicon Research Private Limited), and distributor (Advagen Pharma Limited). The label emphasizes protecting the product from moisture and not accepting if the seal is broken.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-30)

Label for Carvedilol Tablets USP 3.125 mg, a prescription oral tablet. The label states each tablet contains 3.125 mg carvedilol and provides storage instructions to keep below 30°C and protect from moisture. The package contains 30 tablets. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. Includes NDC 72888-034-30 and a barcode.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-05)

Carvedilol Tablets, USP 3.125 mg film-coated tablets label showing NDC 72888-034-05. The label indicates 500 tablets per container, prescription use only, with storage instructions below 30°C and moisture protection. Distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-00)

Label for Carvedilol Tablets USP 6.25 mg, film-coated oral tablets. The package contains 1000 tablets. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. The label includes storage instructions, dosage advisory, and barcode with NDC 72888-035-00.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-01)

Label for Carvedilol Tablets, USP 6.25 mg film-coated tablets. The label indicates a package size of 100 tablets, marked Rx Only. Distributed by Advagen Pharma Limited in New Jersey, USA, and manufactured by Rubicon Research Private Limited in India. Instructions include storage below 30°C and protection from moisture, with a caution not to accept if the seal under the cap is broken. Includes a barcode and a revision date of 07/21.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-30)

Carvedilol Tablets, USP 6.25 mg film-coated tablets in a bottle/carton label by Advagen Pharma Limited. The label indicates 30 tablets, prescription only, with storage and handling instructions. Manufactured by Rubicon Research Private Limited, India, with NDC 72888-035-30.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-05)

Carvedilol Tablets USP 6.25 mg label showing a carton panel that includes the dosage strength, total count of 500 tablets, and dosage form film-coated tablets intended for oral use. The label states manufacturing by Rubicon Research Private Limited and distribution by Advagen Pharma Limited. Safety and storage instructions are visible, along with a barcode and an overprinting area.*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

A line graph depicting cumulative mortality percentages over a 21-month period comparing Carvedilol and placebo groups. The graph shows lower mortality percentages in the Carvedilol group compared to placebo, with a p-value of 0.0014 indicating statistical significance.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

A forest plot comparing hazard ratios across subgroups of patients based on characteristics such as gender, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use. The plot shows hazard ratio values with confidence intervals for each subgroup and an overall summary for all patients.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

A line graph showing cumulative percent mortality over 24 months comparing two groups: Carvedilol and Placebo. The graph indicates lower mortality for the Carvedilol group compared to Placebo, with a p-value of 0.03, suggesting statistical significance.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

A forest plot chart depicting hazard ratios for various subgroups including age, gender, timing after myocardial infarction, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA for MI, congestive heart failure status, diuretics use during MI, presence of angina, hypertension, diabetes, heart rate, and systolic blood pressure. Each subgroup is represented with a hazard ratio and confidence interval plotted along a scale from 0.4 to 1.3.*

FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

Chemical structure of carvedilol, showing its molecular configuration with aromatic rings, hydroxyl group, methoxy group, and amine side chain as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.